The launch of 750mcg teriparatide solution in Australia has seen fluctuating sales . Currently, it’s largely administered for patients with severe osteoporosis who other treatments have failed . Obtaining this stronger formulation presents as challenging due to physician authorization requirements and limited medical center inventory. Despite so… Read More